Skip to main content
OpenTrials

Clinical trial condition

Prostatic Diseases

Explore clinical trials studying Prostatic Diseases. Study availability and eligibility vary by location and protocol.

5,335 public trials 1,046 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Diseases trial results

Active, Not Recruiting

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

NCT02893917

Conditions
Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation, Castration-Resistant Prostate Carcinoma, Genital Diseases, +13 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Diego Medical Center - Hillcrest San Diego, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

NCT03517969

Conditions
Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis

NCT03317392

Conditions
Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1411 locations
View Trial Details
Active, Not Recruiting

Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer

NCT05828082

Conditions
Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • UM Sylvester Comprehensive Cancer Center at Aventura Aventura, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)

NCT00967863

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Institut de Cancérologie de l'Ouest Paul Papin Angers, France
  • Institut Bergonie Bordeaux, France
  • Centre Francois Baclesse Caen, France
  • Centre hospitalier Métropole Savoie Chambéry, France
View all 25 locations
View Trial Details
Active, Not Recruiting

Optilume™ BPH Catheter System in Men With Symptomatic BPH

NCT04131907

Conditions
Benign Prostatic Hyperplasia, Color Vision Defects, Cone Dystrophy, +14 more
Locations
  • Arkansas Urology Little Rock, Arkansas, United States
  • Colorado Clinical Research Golden, Colorado, United States
  • Advanced Urology Institute Daytona Beach, Florida, United States
  • Florida Urology Partners Tampa, Florida, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

ProVee Urethral Expander System IDE Study (ProVIDE)

NCT05186740

Conditions
BPH With Symptomatic Lower Urinary Tract Symptoms, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • Golden State Urology Sacramento, California, United States
  • Urological Research Network Corp Hialeah, Florida, United States
  • Advanced Urology Institute Palm Coast, Florida, United States
  • Tampa Urology LLC Tampa, Florida, United States
View all 16 locations
View Trial Details

Related conditions